VITEK® REVEALTM
integrated within the bioMérieux Sepsis Solution enables same-day Antimicrobial Susceptibility Testing (AST) results to help you manage bloodstream infections.
▶️ Check out this video to discover the new instrument
Benefits
FAST
- Delivers phenotypic AST results in an average of 5.5 hours*
- Direct from positive blood culture
*Tibbetts R, et al. Performance of the Reveal Rapid Antibiotic Susceptibility Testing System on Gram-Negative Blood Cultures at a Large Urban Hospital. Journal of Clinical Microbiology, 2022
Clinical evaluation of the VITEK® REVEAL™ with Gram-negative bacteremia samples in 6 hospitals in France and England - 2021
ACTIONABLE
- Wide antimicrobial coverage for Gram negative bloodstream infections
- Allows faster antimicrobial therapy de-escalation to support antimicrobial stewardship
- Real-time monitoring of Minimum Inhibitory Concentration (MIC) results
INTEGRATED
- Fully integrated within the bioMérieux Sepsis Solution
- Access to bioMérieux’s services from consultancy to installation
- Bi-directional connectivity with MAESTRIA™ or LIS
How it works
3 Main benefits of VITEK REVEAL
Rapid Susceptibility Testing in Sepsis: The REVEAL AST System
The bioMérieux Sepsis Solution
The bioMérieux Sepsis Solution, with the addition of VITEK® REVEAL™ helps manage patient therapy all along the pathway, bringing you rapid and reliable results to support clinical decisions for better patient care.
